ABT vs. AMZN: A Head-to-Head Stock Comparison

Updated on July 7, 2025

Here’s a clear look at ABT and AMZN, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Overview

AMZN’s market capitalization of 2,371.81 billion USD is significantly greater than ABT’s 233.90 billion USD, highlighting its more substantial market valuation.

AMZN carries a higher beta at 1.33, indicating it’s more sensitive to market moves, while ABT (beta: 0.74) exhibits greater stability.

Symbol	ABT	AMZN
Company Name	Abbott Laboratories	Amazon.com, Inc.
Country	US	US
Sector	Healthcare	Consumer Cyclical
Industry	Medical - Devices	Specialty Retail
CEO	Robert B. Ford	Andrew R. Jassy
Price	134.44 USD	223.41 USD
Market Cap	233.90 billion USD	2,371.81 billion USD
Beta	0.74	1.33
Exchange	NYSE	NASDAQ
IPO Date	March 17, 1980	May 15, 1997
ADR	No	No

Historical Performance

This chart compares the performance of ABT and AMZN by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period.

Data is adjusted for dividends and splits.

ABT vs. AMZN: Growth of a $10,000 investment over the past one year.

Profitability

Return on Equity

ABT

30.76%

Medical - Devices Industry

Max: 49.04%
Q3: 9.53%
Median: -7.46%
Q1: -32.83%
Min: -82.64%

In the upper quartile for the Medical - Devices industry, ABT’s Return on Equity of 30.76% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.

AMZN

24.26%

Specialty Retail Industry

Max: 70.52%
Q3: 29.03%
Median: 10.90%
Q1: -7.86%
Min: -57.43%

AMZN’s Return on Equity of 24.26% is on par with the norm for the Specialty Retail industry, indicating its profitability relative to shareholder equity is typical for the sector.

ABT vs. AMZN: A comparison of their ROE against their respective Medical - Devices and Specialty Retail industry benchmarks.

Return on Invested Capital

ABT

19.13%

Medical - Devices Industry

Max: 21.88%
Q3: 6.63%
Median: -1.11%
Q1: -21.08%
Min: -51.95%

In the upper quartile for the Medical - Devices industry, ABT’s Return on Invested Capital of 19.13% signifies a highly effective use of its capital to generate profits when compared to its peers.

AMZN

13.10%

Specialty Retail Industry

Max: 29.46%
Q3: 13.75%
Median: 8.05%
Q1: 0.80%
Min: -17.95%

AMZN’s Return on Invested Capital of 13.10% is in line with the norm for the Specialty Retail industry, reflecting a standard level of efficiency in generating profits from its capital base.

ABT vs. AMZN: A comparison of their ROIC against their respective Medical - Devices and Specialty Retail industry benchmarks.

Net Profit Margin

ABT

31.89%

Medical - Devices Industry

Max: 44.80%
Q3: 9.77%
Median: -5.53%
Q1: -29.37%
Min: -87.68%

A Net Profit Margin of 31.89% places ABT in the upper quartile for the Medical - Devices industry, signifying strong profitability and more effective cost management than most of its peers.

AMZN

10.14%

Specialty Retail Industry

Max: 19.78%
Q3: 8.49%
Median: 3.43%
Q1: -0.69%
Min: -9.88%

A Net Profit Margin of 10.14% places AMZN in the upper quartile for the Specialty Retail industry, signifying strong profitability and more effective cost management than most of its peers.

ABT vs. AMZN: A comparison of their Net Profit Margin against their respective Medical - Devices and Specialty Retail industry benchmarks.

Operating Profit Margin

ABT

16.97%

Medical - Devices Industry

Max: 30.13%
Q3: 13.12%
Median: 3.47%
Q1: -24.42%
Min: -80.56%

An Operating Profit Margin of 16.97% places ABT in the upper quartile for the Medical - Devices industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.

AMZN

11.02%

Specialty Retail Industry

Max: 24.47%
Q3: 11.10%
Median: 5.85%
Q1: 0.66%
Min: -12.62%

AMZN’s Operating Profit Margin of 11.02% is around the midpoint for the Specialty Retail industry, indicating that its efficiency in managing core business operations is typical for the sector.

ABT vs. AMZN: A comparison of their Operating Margin against their respective Medical - Devices and Specialty Retail industry benchmarks.

Profitability at a Glance

Symbol	ABT	AMZN
Return on Equity (TTM)	30.76%	24.26%
Return on Assets (TTM)	16.58%	10.25%
Return on Invested Capital (TTM)	19.13%	13.10%
Net Profit Margin (TTM)	31.89%	10.14%
Operating Profit Margin (TTM)	16.97%	11.02%
Gross Profit Margin (TTM)	55.89%	49.16%

Financial Strength

Current Ratio

ABT

1.78

Medical - Devices Industry

Max: 12.68
Q3: 6.30
Median: 4.05
Q1: 1.85
Min: 0.01

ABT’s Current Ratio of 1.78 falls into the lower quartile for the Medical - Devices industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.

AMZN

1.05

Specialty Retail Industry

Max: 3.24
Q3: 1.99
Median: 1.42
Q1: 1.02
Min: 0.54

AMZN’s Current Ratio of 1.05 aligns with the median group of the Specialty Retail industry, indicating that its short-term liquidity is in line with its sector peers.

ABT vs. AMZN: A comparison of their Current Ratio against their respective Medical - Devices and Specialty Retail industry benchmarks.

Debt-to-Equity Ratio

ABT

0.27

Medical - Devices Industry

Max: 2.34
Q3: 1.09
Median: 0.37
Q1: 0.08
Min: 0.00

ABT’s Debt-to-Equity Ratio of 0.27 is typical for the Medical - Devices industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.

AMZN

0.44

Specialty Retail Industry

Max: 2.72
Q3: 1.42
Median: 0.87
Q1: 0.35
Min: 0.01

AMZN’s Debt-to-Equity Ratio of 0.44 is typical for the Specialty Retail industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.

ABT vs. AMZN: A comparison of their D/E Ratio against their respective Medical - Devices and Specialty Retail industry benchmarks.

Interest Coverage Ratio

ABT

15.39

Medical - Devices Industry

Max: 18.18
Q3: 7.53
Median: 0.85
Q1: -9.80
Min: -33.94

ABT’s Interest Coverage Ratio of 15.39 is in the upper quartile for the Medical - Devices industry, signifying a strong and healthy capacity to meet its interest payments from operating profits.

AMZN

31.13

Specialty Retail Industry

Max: 37.34
Q3: 17.19
Median: 4.28
Q1: 0.11
Min: -23.60

AMZN’s Interest Coverage Ratio of 31.13 is in the upper quartile for the Specialty Retail industry, signifying a strong and healthy capacity to meet its interest payments from operating profits.

ABT vs. AMZN: A comparison of their Interest Coverage against their respective Medical - Devices and Specialty Retail industry benchmarks.

Financial Strength at a Glance

Symbol	ABT	AMZN
Current Ratio (TTM)	1.78	1.05
Quick Ratio (TTM)	1.27	0.84
Debt-to-Equity Ratio (TTM)	0.27	0.44
Debt-to-Asset Ratio (TTM)	0.16	0.21
Net Debt-to-EBITDA Ratio (TTM)	0.60	0.50
Interest Coverage Ratio (TTM)	15.39	31.13

Growth

The following charts compare key year-over-year (YoY) growth metrics for ABT and AMZN. These metrics are based on the companies’ annual financial reports.

Revenue Growth

ABT vs. AMZN: A comparison of their annual year-over-year Revenue Growth.

Earnings Per Share (EPS) Growth

ABT vs. AMZN: A comparison of their annual year-over-year Earnings Per Share (EPS) Growth.

Free Cash Flow Growth

ABT vs. AMZN: A comparison of their annual year-over-year Free Cash Flow Growth.

Dividend

Dividend Yield

ABT

1.70%

Medical - Devices Industry

Max: 3.57%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

With a Dividend Yield of 1.70%, ABT offers a more attractive income stream than most of its peers in the Medical - Devices industry, signaling a strong commitment to shareholder returns.

AMZN

0.00%

Specialty Retail Industry

Max: 5.54%
Q3: 1.52%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

AMZN currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

ABT vs. AMZN: A comparison of their Dividend Yield against their respective Medical - Devices and Specialty Retail industry benchmarks.

Dividend Payout Ratio

ABT

28.92%

Medical - Devices Industry

Max: 102.12%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

ABT’s Dividend Payout Ratio of 28.92% is in the upper quartile for the Medical - Devices industry. This indicates a strong commitment to shareholder returns but also suggests that a smaller portion of earnings is retained for reinvestment compared to many peers.

AMZN

0.00%

Specialty Retail Industry

Max: 177.64%
Q3: 9.49%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

AMZN has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.

ABT vs. AMZN: A comparison of their Payout Ratio against their respective Medical - Devices and Specialty Retail industry benchmarks.

Dividend at a Glance

Symbol	ABT	AMZN
Dividend Yield (TTM)	1.70%	0.00%
Dividend Payout Ratio (TTM)	28.92%	0.00%

Valuation

Price-to-Earnings Ratio

ABT

17.40

Medical - Devices Industry

Max: 90.56
Q3: 56.92
Median: 43.19
Q1: 21.79
Min: 5.55

In the lower quartile for the Medical - Devices industry, ABT’s P/E Ratio of 17.40 suggests the stock may be undervalued compared to its peers, potentially presenting an attractive entry point for investors.

AMZN

35.92

Specialty Retail Industry

Max: 81.45
Q3: 42.51
Median: 25.40
Q1: 12.72
Min: 1.88

AMZN’s P/E Ratio of 35.92 is within the middle range for the Specialty Retail industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.

ABT vs. AMZN: A comparison of their P/E Ratio against their respective Medical - Devices and Specialty Retail industry benchmarks.

Forward P/E to Growth Ratio

ABT

1.73

Medical - Devices Industry

Max: 6.56
Q3: 3.52
Median: 2.22
Q1: 0.55
Min: 0.03

ABT’s Forward PEG Ratio of 1.73 is within the middle range of its peers in the Medical - Devices industry. This suggests a reasonable balance between the stock’s price and its expected growth, aligning with sector valuation norms.

AMZN

1.72

Specialty Retail Industry

Max: 5.90
Q3: 2.79
Median: 1.76
Q1: 0.69
Min: 0.00

AMZN’s Forward PEG Ratio of 1.72 is within the middle range of its peers in the Specialty Retail industry. This suggests a reasonable balance between the stock’s price and its expected growth, aligning with sector valuation norms.

ABT vs. AMZN: A comparison of their Forward PEG Ratio against their respective Medical - Devices and Specialty Retail industry benchmarks.

Price-to-Sales Ratio

ABT

5.52

Medical - Devices Industry

Max: 15.74
Q3: 8.12
Median: 3.40
Q1: 2.37
Min: 0.42

ABT’s P/S Ratio of 5.52 aligns with the market consensus for the Medical - Devices industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.

AMZN

3.65

Specialty Retail Industry

Max: 5.26
Q3: 2.60
Median: 1.29
Q1: 0.41
Min: 0.06

AMZN’s P/S Ratio of 3.65 is in the upper echelon for the Specialty Retail industry. This means the company is valued richly on its revenue stream compared to its peers, suggesting the stock is priced for a high level of future performance.

ABT vs. AMZN: A comparison of their P/S Ratio against their respective Medical - Devices and Specialty Retail industry benchmarks.

Price-to-Book Ratio

ABT

4.81

Medical - Devices Industry

Max: 16.65
Q3: 8.03
Median: 3.73
Q1: 1.92
Min: 0.65

ABT’s P/B Ratio of 4.81 is within the conventional range for the Medical - Devices industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.

AMZN

7.74

Specialty Retail Industry

Max: 12.73
Q3: 6.96
Median: 3.28
Q1: 1.42
Min: 0.24

AMZN’s P/B Ratio of 7.74 is in the upper tier for the Specialty Retail industry. This indicates that investors are paying a premium relative to the company’s net assets, a valuation that hinges on its ability to generate superior profits.

ABT vs. AMZN: A comparison of their P/B Ratio against their respective Medical - Devices and Specialty Retail industry benchmarks.

Valuation at a Glance

Symbol	ABT	AMZN
Price-to-Earnings Ratio (P/E, TTM)	17.40	35.92
Forward PEG Ratio (TTM)	1.73	1.72
Price-to-Sales Ratio (P/S, TTM)	5.52	3.65
Price-to-Book Ratio (P/B, TTM)	4.81	7.74
Price-to-Free Cash Flow Ratio (P/FCF, TTM)	35.14	113.97
EV-to-EBITDA (TTM)	21.49	18.07
EV-to-Sales (TTM)	5.68	3.75